Download PDF
Thromb Haemost 1983; 49(01): 062
DOI: 10.1055/s-0038-1657318
Letter to the Editor
Schattauer GmbH Stuttgart

Relationship Between Antithrombin III, Antiplasmin and Plasma Lipids in a Healthy Population

P Y Scarabin
INSERM U.169, 16 bis, av. P. V. Couturier, F 94807 Villejuif Cedex, France
,
L Bara
Laboratoire d’Hémostase, CHU Broussais, Hôtel-Dieu, Paris
,
A Jacqueson
Laboratoire de Recherche de la DASS, Paris, France
› Author Affiliations
Further Information

Publication History

Received 08 November 1982

Accepted 16 November 1982

Publication Date:
18 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Editorial. Haemostatic factors and coronary heart diseases. Lancet 1981; 01: 22-23
    PubMedGoogle Scholar
  • 2 Meade TW, Chakrabarti R, Haines AP, North WR S, Stirling Y, Thompson SG, Brozovic M. Haemostatic function and cardiovascular death: early results of a prospective study. Lancet 1980; 01: 1050-1054
    PubMedGoogle Scholar
  • 3 Korsan-Bengtsen K, Wilhelmsen L, Tibblin G. Blood coagulation and fibrinolysis in a random sample of 788 men 54 years old: II. Relations of the variables to “risk factors” for myocardial infarction. Thrombos Diathes Haemorrh 1972; 28: 99-108
    PubMedGoogle Scholar
  • 4 Baker IA, Eastham R, Elwood PC, Etherington M, O’Brien JR, Sweetnam PM. Haemostatic factors associated with ischaemic heart disease in men aged 45 to 64 years. The Speedwell study. Br Heart J 1982; 47: 490-494
    CrossrefPubMedGoogle Scholar
  • 5 Smith EB, Staples EM. Haemostatic factors in human aortic intima. Lancet 1981; 01: 1171-1174
    PubMedGoogle Scholar
  • 6 Lowe GD O, Stromberg P, Forbes CD, McArdle BM, Lorimer AR, Prentice CR M. Increased blood viscosity and fibrinolytic inhibitor in type II hyperlipoproteinaemia. Lancet 1982; 1: 472-475
    PubMedGoogle Scholar
  • 7 Winter JH, Bennett B, McTaggart F, Douglas AS. Lipoprotein fractions and antithrombin III consumption during clotting. Thromb Haemostas 1982; 47: 236-238
    PubMedGoogle Scholar